Loading in 2 Seconds...
Loading in 2 Seconds...
Biosimilars Industry is Expected to Grow on Account of Increasing Prevalence of Chronic Diseases
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Biosimilars Market Research Report - Global Industry Analysis,
Size, Growth and Forecast to 2024 – Hexa Research
“Global Biosimilars market size was valued at 3.39 billion
in 2016 and is expected to grow on account of increasing
prevalence of chronic diseases such as cancer and
The Global Biosimilars Market is expected to reach USD 13.1 billion by 2024 on account of increase in the prevalence of
chronic diseases such as cancer, diabetics, cardiac disorders and autoimmune diseases. Rising demand for the cost-
effective therapies is expected to drive the market in the forecast period. Biosimilars are about 30% cheaper than their
counterpart biologics. Furthermore, the patent expiry of the blockbuster drugs is anticipated to provide a lucrative
opportunity for the growth of biosimilars. For instance, a patent for Bevacizumab, sold under the trade name Avastin is
expiring in 2019.
Moreover, increasing government initiatives, speedy drug approvals and reimbursement policies are expected to boost
the market for the biosimilars in the study period. Also, market giants are adopting merger & acquisition strategies to
increase their product portfolio. For instance, in 2015, Pfizer, Inc. acquired Hospira, a key player in biosimilars market.
Browse Details of Report @ https://www.hexaresearch.com/research-report/biosimilars-market
In 2016, oncology was the largest segment, accounting for 32% market share. Increasing prevalence of cancer across the
globe is the key factor driving the growth of the market over the forecast period. For instance, according to the
American Cancer Society, an estimated 1.6 lakh people suffered from cancer in 2016. Also, increasing government
initiatives to provide cost effective treatment to cure deadly diseases will boost the penetration of biosimilar in
developing countries which in turn will increase the market for biosimilar over the forecast period. For instance, WHO
launched a pilot program for prequalifying biosimilar drug, making some of the most expensive treatments for cancer
more widely available in developing countries. Under this initiative, WHO has focused on two essential drug rituximab
(principally used for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukaemia), and trastuzumab
(for the treatment of breast cancer).
In terms of region, Europe dominates the market for biosimilars followed by North America. The dominance of Europe is
due speedy approval of the drug by European regulatory bodies. Furthermore, improving healthcare infrastructure and
ageing population is expected to drive the market over the forecast period. However, Asia Pacific is projected to be the
fastest growing region owing to the increasing disposable income of middle-class families, growing medical tourism and
improving healthcare infrastructure. Furthermore, increasing investment in R&D activities by pharmaceutical giants is
expected to boost the market in the projected period.
Hexa Research has segmented the global biosimilars market based on indication and region:
Segmentation by indication, 2014 - 2024 (USD Million)
• Blood Disorders
• Chronic & Autoimmune Diseases
Segmentation by region, 2014 - 2024 (USD Million)
• North America
• Asia Pacific
• Rest of the world
Key players analyzed:
• Dr. Reddy’s Laboratories Ltd
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
• Pfizer Inc.
• Sandoz International GmbH
• Teva Pharmaceuticals Industries Ltd.
• Amgen Inc.
• STADA Arzneimittel AG
• F. Hoffmann-La Roche Ltd.
Browse Related Category Market Reports@
U.S. Medical Cannabis Market: - U.S. Medical Cannabis has Numerous Health Benefits Particularly by
Patients Suffering from Cancer, Chronic Pain and Diabetes
Teeth Whitening Products Market: - Recommendations from dentist and approvals from the dental
associations encourages consumers to utilize lightening products and is anticipated to boost the market over
the coming few years
Table of Content of Biosimilars Market
Chapter 1. Market Summary
1.1. Market trends & movement
Chapter 2. Global Biosimilars Market Trends: Drivers & Opportunities
2.2. Key industry trends
2.3. Market drivers
2.4. Market restraints
2.5. Value chain analysis
2.6. Porter's Five Forces analysis
Chapter 3. Global Biosimilars Market Trends, By Indication
3.1. Global Biosimilars market movement, by indication, 2016 & 2024
3.1.1. Blood disorders
126.96.36.199. Market estimates and forecast, 2014 - 2024 (USD Million)
188.8.131.52. Market estimates and forecast, 2014 - 2024 (USD Million)
3.1.3. Chronic & Autoimmune Diseases
184.108.40.206. Market estimates and forecast, 2014 - 2024 (USD Million)
220.127.116.11. Market estimates and forecast, 2014 - 2024 (USD Million)
Chapter 4. Global Automotive Suspension Market Trends, By Region
4.1. Global automotive suspension market movement, by region, 2016 & 2024
4.1.1. North America
18.104.22.168. Market estimates and forecast, 2014 - 2024 (USD Million)
22.214.171.124. Market estimates and forecast, by indication, 2014 - 2024 (USD Million)
126.96.36.199. Market estimates and forecast, 2014 - 2024 (USD Million)
188.8.131.52. Market estimates and forecast, by indication, 2014 - 2024 (USD Million)
4.1.3. Asia Pacific
184.108.40.206. Market estimates and forecast, 2014 - 2024 (USD Million)
220.127.116.11. Market estimates and forecast, by indication, 2014 - 2024 (USD Million)
4.1.4. Rest of the World
18.104.22.168. Market estimates and forecast, 2014 - 2024 (USD Million)
22.214.171.124. Market estimates and forecast, by indication, 2014 - 2024 (USD Million)
Chapter 5. Competitive Landscape
5.1. Competitive landscape analysis, 2016
5.2. Strategic framework
5.3. Potential customer base concentration
5.4. Company market positioning
5.5. Company profiles
5.5.1. Dr. Reddy’s Laboratories Ltd.
126.96.36.199. Company Overview
188.8.131.52. Product Benchmarking
184.108.40.206. Financial Performance
220.127.116.11. Recent Initiatives
18.104.22.168. Company Overview
22.214.171.124. Product Benchmarking
126.96.36.199. Financial Performance
188.8.131.52. Recent Initiatives
5.5.3. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
184.108.40.206. Company Overview
220.127.116.11. Product Benchmarking
18.104.22.168. Financial Performance
22.214.171.124. Recent Initiatives
5.5.4. Pfizer Inc.
126.96.36.199. Company Overview
188.8.131.52. Product Benchmarking
184.108.40.206. Financial Performance
220.127.116.11. Recent Initiatives
5.5.5. Sandoz International GmbH
18.104.22.168. Company Overview
22.214.171.124. Product Benchmarking
126.96.36.199. Financial Performance
188.8.131.52. Recent Initiatives
5.5.6. Teva Pharmaceuticals Industries Ltd.
184.108.40.206. Company Overview
220.127.116.11. Product Benchmarking
18.104.22.168. Financial Performance
22.214.171.124. Recent Initiatives
5.5.7. Amgen Inc.
126.96.36.199. Company Overview
188.8.131.52. Product Benchmarking
184.108.40.206. Financial Performance
220.127.116.11. Recent Initiatives
5.5.8. STADA Arzneimittel AG
18.104.22.168. Company Overview
22.214.171.124. Product Benchmarking
126.96.36.199. Financial Performance
188.8.131.52. Recent Initiatives
184.108.40.206. Company Overview
220.127.116.11. Product Benchmarking
18.104.22.168. Financial Performance
22.214.171.124. Recent Initiatives
5.5.10. F. Hoffmann-La Roche Ltd.
126.96.36.199. Company Overview
188.8.131.52. Product Benchmarking
184.108.40.206. Financial Performance
220.127.116.11. Recent Initiatives
5.5.11. List of other vendors
Chapter 6. Methodology and Scope
6.1. Research methodology
6.2. Research Scope & Assumptions
6.3. List of data sources
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Felton Office Plaza
6265 Highway 9
Felton, California 95018
Website - https://www.hexaresearch.com/